NasdaqGS - Delayed Quote • USD
CytomX Therapeutics, Inc. (CTMX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:05 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BELVIN MARCIA Officer | Sale | Mar 19, 2024 | 168,579 |
CAMPOY CARLOS Chief Financial Officer | Sale | Mar 16, 2023 | 38,224 |
CHU YU-WAYE Officer | Stock Award(Grant) | Jan 18, 2024 | 26,250 |
HANNAH ALISON L. Officer | Sale | Jul 20, 2022 | 31,898 |
JONES ELAINE V Director | Purchase | Mar 29, 2023 | 5,142 |
LANDAU JEFFREY B Officer | Sale | Mar 19, 2024 | 117,740 |
MCCARTHY SEAN A. Chief Executive Officer | Conversion of Exercise of derivative security | Mar 26, 2024 | 727,407 |
OGDEN CHRISTOPHER Officer | Sale | Mar 19, 2024 | 85,686 |
PETERSON AMY C Officer | Sale | Mar 16, 2023 | 58,433 |
ROWLAND LLOYD A JR. General Counsel | Sale | Mar 19, 2024 | 117,728 |
Related Tickers
ASMB Assembly Biosciences, Inc.
12.65
-5.31%
SPRO Spero Therapeutics, Inc.
1.4600
+2.10%
NXTC NextCure, Inc.
1.3500
+4.65%
EIGRQ Eiger BioPharmaceuticals, Inc.
2.6700
-12.17%
ALGS Aligos Therapeutics, Inc.
0.7820
-4.40%
GLPG.AS Galapagos NV
26.68
+0.45%
CLRB Cellectar Biosciences, Inc.
3.0300
+0.33%
TIL Instil Bio, Inc.
10.60
+2.02%
NUVB Nuvation Bio Inc.
2.6800
+2.29%
AVRO AVROBIO, Inc.
1.2100
+2.11%